BPCA Capital are working with a group of scientists in Europe, who believe they can deliver
a multi-cancer early detection blood test, that looks for markers in a different
way, and delivers instant results, using lab on a chip technology.
Not requiring a lab to process the blood sample and then provide the results back to the clinical
team, not only speeds up the process, but reduces the cost of testing massively,
making access to it more affordable.
This new MCED could be a real game changer.